Neuromodulation refers to the process by which the activity of neurons in the nervous system is regulated through various mechanisms. Unlike neurotransmitters, which act on specific receptors to produce rapid synaptic transmission, neuromodulators exert their effects over longer time scales and can influence the activity of multiple neurons simultaneously. This modulation can occur at various levels within the nervous system, including the synapse, neuronal circuits, and even entire brain regions. Neuromodulators can be broadly classified into endogenous substances, such as neurotransmitters that also have modulatory effects (e.g., dopamine, serotonin), and exogenous substances, which are artificially introduced into the nervous system to modulate neural activity (e.g., electrical stimulation, pharmacological agents). The effects of neuromodulation can range from altering the excitability of neurons to influencing synaptic plasticity, which underlies learning and memory processes. This field has significant implications for both basic neuroscience research and clinical applications. In research, neuromodulation techniques are employed to dissect the complex interactions within neuronal circuits and understand how these circuits give rise to behavior and cognition. In the clinical realm, neuromodulation therapies are used to treat various neurological and psychiatric disorders, including chronic pain, Parkinson's disease, depression, and epilepsy. Examples of therapies involving neuromodulation encompass deep brain stimulation, transcranial magnetic stimulation, and spinal cord stimulation.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom